Rigel Pharmaceuticals Free Cash Flow Insights

Rigel Pharmaceuticals, Inc. (RIGL)

41.22 -1.11 (-2.62%) USD | NASDAQ | Dec 10, 16:00

41.20 -0.02 (-0.05%) After-Hours: 20:00

View Free Cash Flow for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow Chart

Start Trial

View Historical Data

Start Trial

View Free Cash Flow Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Free Cash Flow Benchmarks

Start Trial

Eli Lilly & Co.	6.436B
Catalyst Pharmaceuticals, Inc.	234.54M
Amicus Therapeutics, Inc.	9.691M
Perspective Therapeutics, Inc.	-106.85M
Nektar Therapeutics	-190.35M

Cash from Operations (Quarterly)	24.03M
Cash from Investing (Quarterly)	-33.18M
Cash from Financing (Quarterly)	4.271M
Free Cash Flow Per Share (Quarterly)	1.254
Free Cash Flow to Equity (Quarterly)	24.18M
Free Cash Flow to Firm (Quarterly)	25.93M
Free Cash Flow Yield	9.00%